Abstract
Background
Prophylactic cranial irradiation (PCI) is used to prevent the development of brain metastases in small cell lung carcinoma. PCI confers an overall survival (OS) benefit in both limited and extensive stage disease.
Aims
We analyze the incidence of symptomatic brain metastases, progression-free survival (PFS) and OS in a cohort of patients who received PCI, in a 5-year period.
Methods
A retrospective review of all patients who had received PCI between 2006 and 2011 at the Whitfield Clinic was completed. Patient- and disease-related characteristics, the number of patients who developed brain metastases, PFS and OS data were collected.
Results
24 patients were identified. 14 (58.3 %) patients were male, 10 (41.7 %) were female, with a mean age of 62.5 years (range 31–78). All patients were smokers. 12 (50 %) patients had limited stage small cell lung cancer (SCLC), 12 (50 %) had extensive stage disease. 2 (8.2 %) patients developed brain metastases post PCI (p = 0.478.) The median PFS for limited stage SCLC was 13 months (range 3–20) and 10 months (range 5–18) for extensive stage SCLC. Median OS was 15 months (range 4–29) in limited stage SCLC, and 11 months (range 5–29) in extensive stage SCLC.
Conclusions
Our study demonstrated a low incidence of symptomatic brain metastases and favourable median PFS and OS in the patients that received PCI, when compared to published phase III data.
References
Bleyer WA, Poplack DG (1985) Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 12:131–148
Hardy J, Smith I, Cherryman G et al (1990) The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer. Br J Cancer 62:684–686
Postmus PE, Sleijfer DT, Haaxma-Rieche H (1989) Chemotherapy for central nervous system metastases from small cell lung cancer: a review. Lung cancer 5:254–263
Felletti R, Souhami RL, Spire SG et al (1985) Social consequences of brain and liver relapse in small cell carcinomas of the bronchus. Radiother Oncol 4:335–339
Arragiada R, Le Chavalier T, Borie F et al (1995) Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 87:183–190
Gregor A, Cull A, Stephens RJ et al (1997) Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomized trial. Eur J Cancer 33:1752–1758
Laplanche A, Monnet I, Riviera A et al (1988) Prophylactic cranial irradiation (PCI) for patients with small cell lung cancer in complete remission. Lung cancer 21:193–201
Auperin A, Arragiada R, Pignon J-P et al (1999) Prophylactic cranial irradiation in small cell lung cancer in complete remission. N Engl J Med 341:476–484
Slotman B, Faivre-Finn C, Kramer G et al (2007) Prophylactic cranial irradiation in extensive stage small cell lung cancer. N Engl J Med 357:664–672
Jeremic B, Shibamoto Y, Acimovic L (1997) Initial versus accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited-stage small cell lung cancer: a randomized study. J Clin Oncol 15(3):893–900
Lishner M, Feld R, Payne DG (1990) Late neurological complications after prophylactic cranial irradiation in patients with small cell lung cancer: the Toronto experience. J Clin Oncol 8(2):211–215
Paumier A, Cuenca X, Le Pechoux C (2011) Prophylactic cranial irradiation in lung cancer. Cancer Treat Rev 37:261–265
Cooper JD, Silverman S, Clement JA (1991) Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted for the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 21:637–643
Andre F, Grunenwald D, Pujol JL et al (2001) Patterns of relapse of N2 non-small cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be considered? Cancer 91:2394–2400
Gore EM, Bae K, Wong SJ et al (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. JCO. 29(3):272–278
Brennan SM, Gregory DL, Stillie A, Herschtal A, Mac Manus M, Ball DL (2010) Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 116(4):888–895
Walenkamp AM, Sonke GS, Sleijfer DT (2009) Clinical and therapeutic aspects of extrapulmonary small cell carcinoma. Cancer Treat Rev 35(3):228–236
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naidoo, J., Kehoe, M., Sasiadek, W. et al. Prophylactic cranial irradiation in small cell lung cancer: a single institution experience. Ir J Med Sci 183, 129–132 (2014). https://doi.org/10.1007/s11845-013-0977-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-013-0977-z